Chrysos Corp. Ltd. · ASX:C79
Chrysos — 2022 Macquarie Western Australia
13 slides from Chrysos's conference presentation, Nov 30, 2022
Slide 1: Faster, more accurate gold analysis
Faster, more accurate gold analysis 2022 Macquarie Western Australia 30 November 2022 Dirk Treasure, Managing Director and CEO
Slide 2: Important notice
Important notice The material in this presentation has been prepared by Chrysos Corporation Limited (ASX: C79) (“Chrysos” or the “Group") and is general background information about Chrysos’ current activities as at the date of this presentation. The information is given in summary form and does not
Slide 3: Chrysos – revolutionising the global mining industry
Chrysos – revolutionising the global mining industry Chrysos is a global provider of novel assay services through its proprietary PhotonAssayTM technology Disruptive Minerals Analysis Lease and Service Model with Industry Accepted Technology Technology Tier 1 Counterparties Displacing Traditional Fi
Slide 4: Our commercialisation journey
Our commercialisation journey The outcome of 20+ years of research and development Prototype Complete JORC and NI43-101 New Customer Announcements 1st PhotonAssayTM Max unit Companies cite PhotonAssayTM data Barrick Bulyanhulu in Tanzania contracts in market announcements MSALABS and PhotonAssayTM P
Slide 5: The Chrysos Vision
The Chrysos Vision To become the world’s leading provider of innovative assay services and technologies Market Challenge: Traditional assay techniques are slow, labour intensive, complex, destructive to the assay sample, and involve Fully-quantitative analysis in as little as 2 minutes! dangerously
Slide 6: An environmentally-friendly solution
An environmentally-friendly solution Substantially better for the environment and significantly safer than fire assay PhotonAssayTM has a substantial positive environmental impact that will continue to grow in tandem with the uptake of the technology ✓ PhotonAssayTM reduces CO2 emissions and elimina
Slide 7: Q1 FY23: Financial and operating highlights
Q1 FY23: Financial and operating highlights Q1 FY23 unaudited Total Revenue of $5.1m, reflecting 9% growth on the previous Quarter $5.1m 740k $703m Total Unaudited Revenue Samples processed Total Contract Value (TCV) • +9% growth on Q4 FY22 of $4.7m • Increased +14% on Q4 FY22 of 651k • Increase of
Slide 8: Sustained revenue growth
Sustained revenue growth New unit deployments and continued strong utilisation are driving revenue growth Unaudited MMAP, AAC & Other Income ■ Minimum Monthly Assay Payments (MMAP) provide sustainable, 6,000 forecastable minimum revenue ■ Q1 FY23 MMAP was $3.8m, up 12% on Q4 FY22 ($3.4m) 5,000 ■ The
Slide 9: Large & unpenetrated TAM
Large & unpenetrated TAM Chrysos has established a global structure to sustain rapid international growth Existing PhotonAssayTM Reach TAM for PhotonAssayTM Units 700 610 Units 600 500 PhotonAssayTM Unit 400 410 On-site Laboratories +561 Units 300 Units 200 100 200 Off-site Laboratories 49 0 Install
Slide 10: Clear growth pathway
Clear growth pathway Clear organic growth plan with potential to expand TAM through additional commodities Business Development Pipeline Multi-commodity Assaying ■ Global networks of laboratories Potential to expand TAM Potential to increase profitability Intertek ALS SGS MSALABS ■ Base metals ■ Add
Slide 11: Experienced leadership team
Experienced leadership team Supported by a well respected and tenured board Senior leadership team Board of Directors Dirk Treasure Rob Adamson Kerry Gleeson Founding CEO & Managing Director Founder & Chairman Director • Metallurgist with a background in both • 20+ years’ experience in mining and fi
Slide 12: Looking ahead
Looking ahead Chrysos is well positioned to continue accelerating its global growth ■ Strong and sustainable growth expected in FY23 ■ On track to meet FY23 Prospectus Revenue target of $26.6m, and EBITDA of $3.2m ■ 49 contracted units, with deployments extending into 2025 ■ 14 currently deployed an
Slide 13: Thank you
Thank you For more information, please visit chrysoscorp.com or contact us at investors@chrysoscorp.com